Saturday 17 October 2026
Export TECH’s income statement to Excel — free account
Bio-Techne Corp
TECH Healthcare Biotechnology
Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.
72.54
0.02
+0.03%
Follow TECH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 9.03% | 5.34% | 3.97% | 3.80% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
9 | 7 | 7 | 5 | |
| 7.07% | 4.22% | 3.12% | 2.96% | ||
ROIC |
7.70% | 4.63% | 3.48% | 3.24% | |
Return on Tangible Assets |
22.38% | 14.27% | 11.09% | 11.06% | |
Average Days of Receivables |
65.06 | 64.68 | 55.43 | 55.17 | |
Free Cash Flow per Share |
1.69 | 1.72 | 1.43 | 1.44 | |
Free Cash Flow |
263.22 | 269.60 | 223.02 | 224.06 | |
Capital Expenditures |
(28.85) | (25.26) | (26.30) | (27.20) | |
| Other line items | |||||
Cash ROIC |
10.23% | 10.80% | 9.13% | 9.29% | |
Accounts Receivable Turnover |
5.74 | 5.36 | 6.04 | 5.97 | |
Accounts Payable Turnover |
16.00 | 15.39 | 14.24 | 13.66 | |
Inventory Turnover |
2.16 | 2.16 | 2.15 | 2.17 | |
Average Days of Payables |
23.43 | 20.21 | 22.68 | 26.12 | |
Days of Inventory on Hand |
171.76 | 173.05 | 177.35 | 176.01 | |
Tax Rate |
(0.24) | (0.26) | (0.29) | (0.27) | |
Research and Development Expense of Revenue |
7.80% | 8.00% | 8.06% | 8.21% | |
Selling, General and Administrative Expense of Revenue |
37.23% | 44.26% | 47.53% | 48.13% | |
Share Based Compensation of Revenue |
3.40% | 3.36% | 3.42% | 3.48% | |
Operating CF/Net income |
1.61 | 2.69 | 3.07 | 3.22 | |
Depreciation/Fixed assets |
0.42 | 0.43 | 0.44 | 0.44 | |
Capex/Depreciation |
(0.30) | (0.25) | (0.25) | (0.26) | |
Revenue per Share |
7.79 | 7.75 | 7.80 | 7.83 | |
Operating CF per Share |
1.87 | 1.89 | 1.60 | 1.62 | |
Capex per Share |
(0.18) | (0.16) | (0.17) | (0.17) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates